You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
AstraZeneca
McKesson
Mallinckrodt
Express Scripts
McKinsey

Last Updated: August 3, 2020

DrugPatentWatch Database Preview

Atracurium besylate - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for atracurium besylate and what is the scope of freedom to operate?

Atracurium besylate is the generic ingredient in four branded drugs marketed by Aurobindo Pharma Ltd, Baxter Hlthcare, Baxter Hlthcare Corp, Hospira, Hospira Inc, Meitheal, Mylan Labs Ltd, Teva Parenteral, Watson Pharms Teva, West-ward Pharms Int, and Watson Labs Inc, and is included in twenty-three NDAs. Additional information is available in the individual branded drug profile pages.

There are sixteen drug master file entries for atracurium besylate. Three suppliers are listed for this compound.

Recent Clinical Trials for atracurium besylate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Sir Ganga Ram HospitalN/A
Fayoum University HospitalN/A
Mahidol UniversityPhase 4

See all atracurium besylate clinical trials

Pharmacology for atracurium besylate
Medical Subject Heading (MeSH) Categories for atracurium besylate

US Patents and Regulatory Information for atracurium besylate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira ATRACURIUM BESYLATE PRESERVATIVE FREE atracurium besylate INJECTABLE;INJECTION 074639-001 Mar 25, 1997 DISCN No No   Start Trial   Start Trial   Start Trial
Hospira TRACRIUM atracurium besylate INJECTABLE;INJECTION 018831-002 Jun 20, 1985 DISCN Yes No   Start Trial   Start Trial   Start Trial
Mylan Labs Ltd ATRACURIUM BESYLATE PRESERVATIVE FREE atracurium besylate INJECTABLE;INJECTION 206001-001 Apr 7, 2017 DISCN No No   Start Trial   Start Trial   Start Trial
Baxter Hlthcare Corp ATRACURIUM BESYLATE PRESERVATIVE FREE atracurium besylate INJECTABLE;INJECTION 074768-001 Jan 23, 1997 DISCN No No   Start Trial   Start Trial   Start Trial
Hospira Inc ATRACURIUM BESYLATE PRESERVATIVE FREE atracurium besylate INJECTABLE;INJECTION 090782-001 Oct 18, 2012 AP RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
McKinsey
McKesson
Moodys
Boehringer Ingelheim
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.